These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7302777)

  • 1. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
    S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Eiriksson Ce; Brogden RN
    Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary clinical and experimental data on a new anti-arrhythmic drug: lorcainide].
    Pretolani E; Battistini G; Iosa G; Mambelli M; Pigini G; Zoli I
    Minerva Med; 1980 Apr; 71(13):975-80. PubMed ID: 7375011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorcainide -- an anti-arrhythmic agent for ventricular arrhythmias.
    Myburgh DP; Goldman AP; Schamroth JM
    S Afr Med J; 1980 Feb; 57(7):236-9. PubMed ID: 7404136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias.
    Cowley AJ; Skene A; Stainer K; Hampton JR
    Int J Cardiol; 1993 Jul; 40(2):161-6. PubMed ID: 8349379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Controlled comparison of lorcainide and lidocaine.
    Schmidt G; Klein G; Wirtzfeld A
    Eur J Clin Pharmacol; 1985; 27(6):633-6. PubMed ID: 2580712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
    Somani P
    Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.
    Somani P; di Giorgi S
    Chest; 1980 Oct; 78(4):658-60. PubMed ID: 7418495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of lorcainide on experimental arrhythmias in comparison with other antiarrhythmic agents].
    Ma X; Li ZW
    Yao Xue Xue Bao; 1986 Apr; 21(4):241-5. PubMed ID: 3788590
    [No Abstract]   [Full Text] [Related]  

  • 17. The true lorcainide story.
    Chalmers I
    BMJ; 2015 Jan; 350():h287. PubMed ID: 25630497
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainide.
    Hohnloser SH; Podrid PJ; Lown B
    Am Heart J; 1988 Apr; 115(4):824-30. PubMed ID: 3354411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.